Comparative coronary risks of apixaban, rivaroxaban and dabigatran:a meta-analysis and adjusted indirect comparison

Loke, Yoon K, Pradhan, Shiva, Yeong, Jessica Ka-Yan and Kwok, Chun Shing (2014) Comparative coronary risks of apixaban, rivaroxaban and dabigatran:a meta-analysis and adjusted indirect comparison. British Journal of Clinical Pharmacology, 78 (4). 707–717. ISSN 0306-5251

Full text not available from this repository. (Request a copy)

Abstract

There are concerns regarding increased risk of acute coronary syndrome with dabigatran. We aimed to assess whether alternative treatment options such as rivaroxaban or apixaban carry a similar risk as compared to dabigatran.

Item Type: Article
Additional Information: This article is protected by copyright. All rights reserved.
Uncontrolled Keywords: acute coronary syndrome,apixaban,dabigatran
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: Pure Connector
Date Deposited: 07 Jul 2014 13:14
Last Modified: 24 Jul 2019 20:00
URI: https://ueaeprints.uea.ac.uk/id/eprint/48919
DOI: 10.1111/bcp.12376

Actions (login required)

View Item View Item